ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PAR REPORTS PAIN REDUCTION IN 83% OF OSTEOARTHRITIS PATIENTS
Published: 10/10/17, 09:12am (AEST)•5 pages